Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2018 December;60(4) > Panminerva Medica 2018 December;60(4):145-50

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Panminerva Medica 2018 December;60(4):145-50

DOI: 10.23736/S0031-0808.18.03485-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Clinical significance of serum-terminal pro-B-type natriuretic peptide in patients with acute cerebral stroke

Qi YANG 1, Chang LI 2, Le WANG 3, Bo WEI 4

1 Department of Gynecology and Obstetrics, China-Japan Union Hospital of Jilin University, Changchun, China; 2 Very Immune Compromised Patient Alert (VIP) Unit, China-Japan Union Hospital of Jilin University, Changchun, China; 3 Department of Ophthalmology, The First Hospital of Jilin University, Changchun, China; 4 Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, China



BACKGROUND: To investigate the relationships of the changes of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) level with the severity of the disease (infarct size, amount of bleeding, National Institutes of Health Stroke Scale [NIHSS] Score and Glasgow Coma Scale [GCS] Score) and prognosis in acute cerebral stroke patients.
METHODS: Acute cerebral stroke patients admitted to our hospital from August 2015 to August 2017 were enrolled in this study. The NT-proBNP level, infarct size, amount of bleeding, NIHSS Score, GCS Score and Modified Rankin Scale (MRS) Score at 3 months after onset in patients in cerebral infarction group and cerebral hemorrhage group were observed at 24 h, (5±2) d and (12±2) d. The correlations of NT-proBNP level with the severity of the disease and MRS Score at 3 months after onset were also analyzed.
RESULTS: The serum NT-proBNP levels in patients in infarction group and hemorrhage group were significantly higher than those in control group at 24 h and (5±2) d after onset (P<0.01). The serum NT-proBNP level at 24 h after onset in hemorrhage group had statistically significant difference from that at (5±2) d in the same group, and those at 24 h and (5±2) d after onset in infarction group and hemorrhage group had statistically significant difference from those at (12±2) d in the same group (P<0.01). There were significant differences in NT-proBNP levels among subgroups with different NIHSS scores (P<0.01). GCS Score was significantly correlated with NT-proBNP level (P<0.01). The higher the level of serum NT-proBNP, the higher the patient’s MRS Score at 3 months after onset was.
CONCLUSIONS: Serum NT-proBNP level can be used as a serum biological indicator to evaluate the severity and prognosis of cerebral stroke patients.


KEY WORDS: pro-brain natriuretic peptide (1-76) - Stroke - Glasgow Coma Scale - Prognosis

inizio pagina